Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paolo Fiorina, M.D.

Co-Author

This page shows the publications co-authored by Paolo Fiorina and James Markmann.
Connection Strength

1.343
  1. The IGFBP3/TMEM219 pathway regulates beta cell homeostasis. Nat Commun. 2022 02 03; 13(1):684.
    View in: PubMed
    Score: 0.246
  2. Regulatory B Cells in Autoimmune Diabetes. J Immunol. 2021 03 15; 206(6):1117-1125.
    View in: PubMed
    Score: 0.231
  3. PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes. Sci Transl Med. 2017 Nov 15; 9(416).
    View in: PubMed
    Score: 0.184
  4. Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site. Acta Diabetol. 2015 Oct; 52(5):917-27.
    View in: PubMed
    Score: 0.153
  5. TIM4 Regulates the Anti-Islet Th2 Alloimmune Response. Cell Transplant. 2015; 24(8):1599-1614.
    View in: PubMed
    Score: 0.142
  6. Inotuzumab ozogamicin murine analog-mediated B-cell depletion reduces anti-islet allo- and autoimmune responses. Diabetes. 2012 Jan; 61(1):155-65.
    View in: PubMed
    Score: 0.121
  7. IL-21 is an antitolerogenic cytokine of the late-phase alloimmune response. Diabetes. 2011 Dec; 60(12):3223-34.
    View in: PubMed
    Score: 0.121
  8. A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice. Diabetes. 2010 Sep; 59(9):2253-64.
    View in: PubMed
    Score: 0.112
  9. B-cell depletion improves islet allograft survival with anti-CD45RB. Cell Transplant. 2014 Jan; 23(1):51-8.
    View in: PubMed
    Score: 0.033
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.